Board Change • May 20
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 2 highly experienced directors. No independent directors (5 non-independent directors). Director of Research, Development & Innovation and Director Angelica Jozar was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Duyuru • Mar 12
PT Avia Avian Tbk, Annual General Meeting, Apr 09, 2026 PT Avia Avian Tbk, Annual General Meeting, Apr 09, 2026. Duyuru • Mar 03
PT Avia Avian Tbk, Annual General Meeting, Apr 10, 2025 PT Avia Avian Tbk, Annual General Meeting, Apr 10, 2025, at 09:30 FLE Standard Time. New Risk • Nov 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (101% cash payout ratio). Share price has been volatile over the past 3 months (7.8% average weekly change). Reported Earnings • Nov 05
Third quarter 2024 earnings released: EPS: Rp5.81 (vs Rp5.39 in 3Q 2023) Third quarter 2024 results: EPS: Rp5.81 (up from Rp5.39 in 3Q 2023). Revenue: Rp1.78t (up 7.8% from 3Q 2023). Net income: Rp352.2b (up 5.5% from 3Q 2023). Profit margin: 20% (in line with 3Q 2023). Revenue is forecast to grow 8.1% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Buy Or Sell Opportunity • Sep 06
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 13% to €0.026. The fair value is estimated to be €0.033, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.5% over the last year. Earnings per share has grown by 15%. Revenue is forecast to grow by 18% in 2 years. Earnings are forecast to grow by 17% in the next 2 years. Buy Or Sell Opportunity • Aug 04
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 12% to €0.025. The fair value is estimated to be €0.032, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.5% over the last year. Earnings per share has grown by 15%. Revenue is forecast to grow by 19% in 2 years. Earnings are forecast to grow by 14% in the next 2 years. Reported Earnings • Aug 02
Second quarter 2024 earnings released: EPS: Rp5.90 (vs Rp6.29 in 2Q 2023) Second quarter 2024 results: EPS: Rp5.90 (down from Rp6.29 in 2Q 2023). Revenue: Rp1.72t (flat on 2Q 2023). Net income: Rp362.0b (down 7.1% from 2Q 2023). Profit margin: 21% (down from 23% in 2Q 2023). Revenue is forecast to grow 8.4% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Reported Earnings • Apr 30
First quarter 2024 earnings released: EPS: Rp7.24 (vs Rp6.73 in 1Q 2023) First quarter 2024 results: EPS: Rp7.24 (up from Rp6.73 in 1Q 2023). Revenue: Rp1.91t (up 6.9% from 1Q 2023). Net income: Rp446.2b (up 7.1% from 1Q 2023). Profit margin: 23% (in line with 1Q 2023). Revenue is forecast to grow 8.1% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Upcoming Dividend • Apr 16
Upcoming dividend of Rp11.00 per share Eligible shareholders must have bought the stock before 23 April 2024. Payment date: 30 April 2024. Payout ratio is on the higher end at 93%, and the cash payout ratio is above 100%. Trailing yield: 4.0%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (4.8%). Board Change • Apr 04
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Independent Commissioner Mohammad Rachman Soejoeti was the last independent director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 29
Full year 2023 earnings released: EPS: Rp26.51 (vs Rp22.61 in FY 2022) Full year 2023 results: EPS: Rp26.51 (up from Rp22.61 in FY 2022). Revenue: Rp7.02t (up 4.8% from FY 2022). Net income: Rp1.64t (up 17% from FY 2022). Profit margin: 23% (up from 21% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.9% p.a. on average during the next 2 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. New Risk • Jan 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (93% payout ratio). Share price has been volatile over the past 3 months (7.1% average weekly change). Buy Or Sell Opportunity • Jan 24
Now 24% overvalued after recent price rise Over the last 90 days, the stock has risen 14% to €0.033. The fair value is estimated to be €0.026, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 5.1% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 20% in 2 years. Earnings are forecast to grow by 25% in the next 2 years. Reported Earnings • Nov 02
Third quarter 2023 earnings released: EPS: Rp5.39 (vs Rp4.89 in 3Q 2022) Third quarter 2023 results: EPS: Rp5.39 (up from Rp4.89 in 3Q 2022). Revenue: Rp1.66t (up 4.9% from 3Q 2022). Net income: Rp333.7b (up 10% from 3Q 2022). Profit margin: 20% (up from 19% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Upcoming Dividend • Oct 18
Upcoming dividend of Rp11.00 per share at 4.2% yield Eligible shareholders must have bought the stock before 24 October 2023. Payment date: 31 October 2023. Payout ratio is a comfortable 48% and this is well supported by cash flows. Trailing yield: 4.2%. Lower than top quartile of German dividend payers (5.0%). Lower than average of industry peers (6.3%). Board Change • Sep 18
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Independent Commissioner Mohammad Rachman Soejoeti was the last independent director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Sep 01
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Independent Commissioner Mohammad Rachman Soejoeti was the last independent director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 03
Second quarter 2023 earnings released: EPS: Rp6.29 (vs Rp6.32 in 2Q 2022) Second quarter 2023 results: EPS: Rp6.29 (down from Rp6.32 in 2Q 2022). Revenue: Rp1.73t (flat on 2Q 2022). Net income: Rp389.9b (flat on 2Q 2022). Profit margin: 23% (in line with 2Q 2022). Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 1.8% growth forecast for the Chemicals industry in Germany. Board Change • May 11
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Independent Commissioner Mohammad Rachman Soejoeti was the last independent director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Apr 25
Upcoming dividend of Rp11.00 per share at 3.9% yield Eligible shareholders must have bought the stock before 02 May 2023. Payment date: 09 May 2023. Payout ratio and cash payout ratio are on the higher end at 93% and 87% respectively. Trailing yield: 3.9%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.4%). Board Change • Nov 17
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Independent Commissioner Mohammad Noor Soejoeti was the last independent director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 04
Second quarter 2022 earnings released Second quarter 2022 results: EPS: Rp6.32. Revenue: Rp1.74t (flat on 2Q 2021). Net income: Rp391.7b (up Rp391.7b from 2Q 2021). Profit margin: 23% (up from null in 2Q 2021). Over the next year, revenue is forecast to grow 19%, compared to a 3.7% growth forecast for the industry in Germany. Board Change • Aug 02
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Independent Commissioner Mohammad Noor Soejoeti was the last independent director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.